Web Analytics

3 Latest Announced Rounds

  • $4,000,000
    Seed

    2 Investors

    Technology, Information and Internet
    Dec 11th, 2024
  • $1,000,000
    Seed

    1 Investors

    Financial Services
    Dec 11th, 2024
  • $8,000,000
    Series A

    3 Investors

    Software Development
    Dec 11th, 2024
$1,065.81M Raised in 67 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Injectsense Inc.

start up
United States - Emeryville , CA
  • 16/11/2023
  • Unknown
  • $9,400,000

Injectsense: Improved Care Through Continuous Information

Injectsense enables tracking of progressive disease indicators and improved therapy management by providing continuous, clinically actionable information through an injectable ultra-miniature sensor coupled with a secure digital health platform. Our sensor, which can be delivered during a single doctor's office visit, transforms the care model by enabling medical teams to track the disease at the pace of its evolution, whether months or years, receive early warning signs and provide preventive therapy. The configurable-on-demand sensor monitors patients 24/7, requires no patient lifestyle changes and reduces the need for medical office visits. More significantly, it allows physicians to establish an individual patient baseline for comparison, to receive data quickly at any time of day, to see histories and hourly dynamic disease state before irreversible damage is done, and to increase the effectiveness of drug therapy by tracking the effects of pharmaceuticals on key indicators over time.


Related People

Ariel C.Co Founder

Ariel C. United States - San Francisco Bay Area

Veteran entrepreneur with 25+ years of extensive results-oriented corporate and technical leadership. Strong background in organizational management, fundraising, team building, international business development, IP strategy and engineering. Versed in a wide range of electronic design architectures across multiple domains, with experience in developing, managing and marketing products including medical devices and systems with embedded smart sensors for pressure, motion and chemical measurement; as well as low power electronics, RF & communications ICs, and MEMS. Skilled in intercultural communications, business practices and protocols; managed offices in Europe and Japan, fluent French, English.

Organizational Management
Co-founded 4 companies, built high-performing engineering and sales teams in the microprocessor and sensor industries. Equally comfortable with forecasting, budgeting, planning, term sheet discussions, technology transfer negotiations or establishing new medical device supply chains. Strong familiarity with global strategies and market entry / growth requirements for start-ups in emerging technology as well as with the cross-functional needs of large matrixed companies.

Fundraising / M&A / Business Development
Extensive experience in fundraising for multiple companies including university spin-offs, especially Series A and B rounds. Focused on securing funding from the private investment community. Managed M&A target research for complementary technologies, due diligence processes and M&A terms for two successful acquisitions. Advised on a successful $100 million IPO in Europe. Secured more than $375 million dollars in contracts for cutting-edge semiconductor products, medical devices, sensors, and intellectual property. Proven track record in driving business through technology transfer, intellectual property strategy and licensing, and OEM / joint marketing agreements.

Specialties: o Marketing (management, strategic, product), Technology platform and Applications strategy, Market entry and Alternate channels assessment,

o Business development/planning, Emerging Technology assessment and commercialization, Market and competitive Analysis, benchmarking

o Areas of focus (ASIC A/M-S & RF, MEMS and EDA) applied in particular to MEMS sensor integration from inertial, biomedical, RF interface for communication ASIC or integrated SIP/CSP, module and system integrations